首页> 美国卫生研究院文献>Adolescent Health Medicine and Therapeutics >Asthma control in adolescents: role of leukotriene inhibitors
【2h】

Asthma control in adolescents: role of leukotriene inhibitors

机译:青少年哮喘控制:白三烯抑制剂的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Asthma is a chronic inflammatory disease of the airways and is a big burden worldwide. It affects both children and adults, but it is insufficiently studied in adolescents, although this age group has important peculiarities and is challenging to treat, due to, but not exclusively because of, lack of adherence to treatment instructions. Evidence-based guidelines for the treatment of asthma targeting specifically adolescents are lacking, due to the fact that most studies are conducted either on children or in adults. Exercise-induced asthma occurs commonly in adolescents, leading to impaired physical activity. This review describes current treatment options for asthma in adolescents, focusing on leukotriene receptor antagonists, both as a monotherapy and as an add-on therapy for optimal asthma control.
机译:哮喘是气道的慢性炎性疾病,在全世界范围内都是很大的负担。它影响儿童和成人,但在青少年中研究不足,尽管该年龄组具有重要的特点,并且由于(但不仅限于)缺乏治疗指导,因此难以治疗。由于大多数研究都是针对儿童或成人进行的,因此缺乏针对青少年的哮喘治疗的循证指南。运动诱发的哮喘通常发生在青少年中,导致体育活动受损。这篇综述描述了目前用于青少年哮喘的治疗选择,重点是白三烯受体拮抗剂,既作为单一疗法,又作为最佳哮喘控制的附加疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号